Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prisma Biotech
Taipei, Taipei, Taiwan
- Ownership
- Private
- Development stage
- Other
01
Overview
Prisma Biotech distributes and supports advanced genomics and NGS tools across Taiwan and Asia-Pacific, enabling clinical and research laboratories to deploy modern sequencing, microarray, and genetic analysis workflows; it is a leading distributor, rather than a developer, thus clinical results derive from its partners’ technologies like Illumina and Parse Biosciences.
- Therapeutic areas
- OncologyInfectious DiseasesWomen's HealthOther
- Modalities
- DeviceIn-vitro diagnosticNext-generation sequencing platform
- Industry
- Biomedical IT and Biomedical Data Platforms
02
Partnerships
IlluminaParse BiosciencesCombimatrix (historical)
Beyond the preview
Go deeper on Prisma Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prisma Biotech.